(Q33303367)

25 July 2017

title

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population (English)

1 reference

25 July 2017

0 references

1 reference

diabetic macular edema

1 reference

Atul Kumar

1

1 reference

25 July 2017

Subijay Sinha

series ordinal

2

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

Indian Journal of Ophthalmology

25 July 2017

published in

1 reference

25 July 2017

volume

55

1 reference

25 July 2017

issue

6

1 reference

25 July 2017

page(s)

451-455

1 reference

Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity

25 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635996

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635996

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635996

Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635996

Ocular morbidity associated with intravitreal triamcinolone acetonide

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635996

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635996

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635996

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635996

Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635996

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635996

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635996

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635996

[Intravitreal bevacizumab for neovascular age-related macular degeneration]

31 October 2018

1 reference

12 December 2020

Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study

1 reference

12 December 2020

Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy

1 reference

12 December 2020

Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion

1 reference

12 December 2020

Regression of neovascular iris vessels by intravitreal injection of bevacizumab

1 reference

12 December 2020

A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema

1 reference

12 December 2020

Rapid regression of disc neovascularization in a patient with proliferative diabetic retinopathy following adjunctive intravitreal bevacizumab

1 reference

12 December 2020

Identifiers

DOI

10.4103/0301-4738.36481

1 reference

release_hbacvzlwqvgm5ph4epz6wxpt7y

25 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hbacvzlwqvgm5ph4epz6wxpt7y

24 November 2022

mapped directly with Wikidata item

PMC publication ID

2635996

1 reference

25 July 2017

1 reference